University of Cambridge > > Milner Therapeutics Institute > Milner Therapeutics Symposium 2023

Milner Therapeutics Symposium 2023

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact ndo23.

Join us for our 2023 Therapeutics Symposium on Wednesday 5th July, which will once again take place as a hybrid event. A fantastic line-up of speakers will present live at West Road Concert Hall in Cambridge, and talks will be streamed to an online platform.

Our Annual Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner Therapeutics Institute partner organisations.


Oncology · CNS therapeutics · Epigenetics · Emerging technologies · Disease-relevant models in target discovery


Serena  Nik-Zainal (Early Cancer Institute, University of Cambridge), Wolf Reik (Altos Labs), Karen Duff (​UK Dementia Research Institute at University College London), Allan Bradley (Cambridge Institute of Therapeutic Immunology & Infectious Disease and Kymab), Cigall Kadoch (Dana Farber Cancer Institute and Harvard Medical School) Mene Pangalos (AstraZeneca), Manav Pathania (Department of Oncology and Milner Therapeutics Institute), Debora Lucarelli (Enhanc3d Genomics) and David Walter and Douglas Ross-Thriepland (AstraZeneca Cancer Research Horizons Functional Genomics Centre)

This talk is part of the Milner Therapeutics Institute series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity